Document is current
Any future updates will be listed below
-
Authors
ten Hacken, Elisa
Clement, Kendell
Li, Shuqiang
Hernández-Sánchez, María
Redd, Robert
Wang, Shu
Ruff, David
Gruber, Michaela
Baranowski, Kaitlyn
Jacob, Jose
Flynn, James
Jones, Keith W.
Neuberg, Donna
Livak, Kenneth J.
Pinello, Luca
Wu, Catherine J.
-
Funding
Funding for this research was provided by:
National Cancer Institute
National Human Genome Research Institute
- License Information
-
More Information
Article History
Received: 11 May 2020
Accepted: 1 October 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: C.J.W. is equity holder of BionTech, Inc., and receives research funding from Pharmacyclics. S.W., D.R., J.J., J.F., and K.W.J. are employees of Mission Bio., Inc. L.P. has financial interests in Edilytics, Inc. K.C. is an employee, shareholder, and officer of Edilytics, Inc. The interests of L.P. and K.C. were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. All other authors do not have any relevant conflict of interest.
